
Highly accurate chromosomal screening from a simple blood test — no risk to your baby, no needles near your womb. Expert counselling before and after your results by Dr. Kunda Shahane.
NIPT (Non-Invasive Prenatal Testing) — also called cell-free DNA testing or NIPS — is a highly accurate prenatal screening test that analyses tiny fragments of fetal DNA circulating in the mother's blood. During pregnancy, small amounts of DNA from the placenta enter the mother's bloodstream. NIPT analyses this DNA to estimate the likelihood of certain chromosomal conditions in the baby.
The test involves only a routine blood draw from the mother — there is no needle near the baby, no risk of miscarriage, and no procedure involving the uterus or amniotic fluid whatsoever.
At Mayflower Clinic, Dr. Kunda Shahane provides expert pre-test counselling to help you understand what NIPT can and cannot tell you, coordinates with certified NIPT laboratories, and provides full post-result counselling once your report arrives — so you are never left interpreting a complex result alone.
| Also called | Cell-free DNA test · NIPS · cffDNA test |
| Test type | Screening (not diagnostic) |
| Sample | Maternal blood (simple venous blood draw) |
| Risk to baby | None — no invasive procedure |
| Can be done from | 10 weeks of pregnancy |
| Optimal timing | 12–16 weeks |
| Results turnaround | 7–14 working days |
| Counselling | Pre- and post-result by Dr. Kunda Shahane |
NIPT is one of the most accurate prenatal screening tests available — but it is not a diagnostic test. A high-risk or positive NIPT result does not confirm that your baby has a chromosomal condition. It means the risk is significantly elevated and further investigation is needed. A positive NIPT must always be confirmed by an invasive diagnostic test — amniocentesis or CVS — before any clinical decisions are made. Equally, a low-risk NIPT result is highly reassuring but does not completely exclude all chromosomal conditions. Dr. Kunda Shahane will explain exactly what your result means in your specific context.
| Condition | What It Means | Detection Rate |
|---|---|---|
| Trisomy 21 — Down Syndrome | Extra copy of chromosome 21. Most common chromosomal condition. Causes intellectual disability and characteristic physical features. | >99% |
| Trisomy 18 — Edwards Syndrome | Extra copy of chromosome 18. Associated with severe developmental abnormalities and is often not compatible with life. | >97% |
| Trisomy 13 — Patau Syndrome | Extra copy of chromosome 13. Severe structural abnormalities affecting brain, heart, and other organs. | ~91% |
| Turner Syndrome (45,X) | Missing X chromosome in females. Causes short stature, ovarian insufficiency, and some heart defects. | ~90%+ |
| Klinefelter Syndrome (XXY) | Extra X chromosome in males. Usually mild — may affect fertility and development. Many individuals are undiagnosed. | ~90%+ |
| DiGeorge Syndrome (22q11) — Extended Panel | Small deletion of chromosome 22. Associated with heart defects, immune problems, and learning difficulties. Available on extended NIPT panels. | Panel dependent |
Understanding the difference between screening and diagnostic tests helps you make the right choice for your pregnancy. Dr. Kunda Shahane will always recommend the most appropriate pathway for your specific situation.
| Feature | Combined Screening (NT + blood) | NIPT | Amniocentesis / CVS |
|---|---|---|---|
| Test type | Screening | Screening | Diagnostic |
| Sample | Ultrasound + blood | Maternal blood only | Amniotic fluid / placental tissue |
| Risk to baby | None | None | ~0.1–1% miscarriage risk |
| Down syndrome detection | ~90% | >99% | >99.9% (definitive) |
| False positive rate | ~3–5% | <1% | Negligible |
| When can it be done | 11–13+6 weeks | From 10 weeks | From 11 weeks (CVS) / 15 weeks (amnio) |
| What it tells you | Risk estimate | High accuracy risk estimate | Definitive yes or no |
| Can confirm diagnosis? | No | No | Yes |
| Additional findings | Fetal anatomy, NT, nasal bone | Chromosomal risk only | Full chromosome analysis + optional microarray |
NIPT can be offered to any pregnant woman from 10 weeks, but it is particularly recommended in the following situations.
Before the blood sample is taken, Dr. Kunda explains what NIPT can detect, what it cannot detect, what a high-risk result means, and what your next steps would be in either scenario. This ensures you make a fully informed decision about whether NIPT is right for you.
A small sample of your blood (typically 10–20 mL) is drawn from a vein in your arm — exactly like a routine blood test. No special preparation is needed. The sample is labelled and dispatched to a certified NIPT laboratory by Dr. Kunda's team.
The laboratory extracts and analyses the cell-free fetal DNA in your blood sample. The bioinformatics pipeline calculates the ratio of chromosomal material to estimate the risk of trisomies and other conditions. This process takes 7–14 working days.
The NIPT report is sent directly to Dr. Kunda Shahane. She reviews the result in the context of your NT scan findings, combined screening result (if done), and medical history before contacting you. You are never called with a result without prior review.
Dr. Kunda contacts you personally. For low-risk results, she explains what the result means and what routine care to continue. For high-risk results, she arranges a dedicated counselling session to explain the finding, confirm it with amniocentesis or CVS if appropriate, and discuss all available options compassionately.
"NIPT has transformed prenatal screening — but it has also introduced a new kind of anxiety for parents who receive a positive result and do not yet understand what it means. My role is to ensure that every family who comes to Mayflower for NIPT understands exactly what the test can tell them before they take it — and receives a careful, honest, unhurried explanation of their results afterwards. A number on a report is not a diagnosis. The conversation that follows is what matters most."— Dr. Kunda Shahane, MBBS, MS (Obs & Gynae), FIFM, FMF (London)
Dr. Kunda Shahane will help you understand your options, choose the right test, and interpret your results with complete clarity.
Mayflower Fetal Medicine Centre strictly complies with the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994. All prenatal diagnostic and screening services at this centre are performed exclusively for lawful medical indications. Sex determination and sex-selective practices are strictly prohibited and punishable by law. Disclosure of fetal sex is not performed at this centre under any circumstances.
Medical Disclaimer: This page is for general patient education only and does not constitute medical advice, diagnosis, or treatment. NIPT is a screening test — a positive result requires confirmation by invasive diagnostic testing before any clinical decisions are made. Please consult Dr. Kunda Shahane or your treating obstetrician for advice specific to your pregnancy. In an emergency, contact your nearest hospital immediately.
Mayflower Fetal Medicine & High-Risk Pregnancy Centre, Dhantoli, Nagpur, provides fetal ultrasound, prenatal diagnosis, fetal echocardiography, Doppler studies, genetic counseling and high-risk pregnancy care under Dr. Kunda Shahane.

Fetal Echocardiography: Detecting Heart Defects before Birth…

High-Risk Pregnancy: How Fetal Medicine Supports Moms…
Surdham Complex, Behind Silver Palace Building, 2nd Lane from Panchsheel Sq., Opp. Yashwant Stadium, Dhantoli Nagpur - 440012
07126692706
whatsapp 8087471244
